Table 4 Risk factors of shunt-dependent hydrocephalus in aneurysmal SAH patients without hydrocephalus upon arrival at the hospital
Without shunt-dependent hydrocephalus N = 71 | With shunt-dependent hydrocephalus N = 15 | P value | OR | 95% CI | ||
|---|---|---|---|---|---|---|
Sex (male/female) | 20/51 | 3/12 | 0.384 | 0.638 | 0.163-2.501 | |
Mean age at onset | 52.92 ± 11.85 | 57.93 ± 12.66 | 0.146 | |||
Mean blood pressure on presentation | ||||||
Mean Systolic Blood pressure (mmHg) | 144.59 ± 22.92 | 148.13 ± 24.77 | 0.593 | |||
Mean diastolic Blood pressure (mmHg) | 81.84 ± 12.734 | 78.07 ± 14.67 | 0.312 | |||
Mean GCS on presentation | 13.17 ± 2.82 | 10.87 ± 4.17 | 0.01 | |||
Mean modified Fisher SAH grade on presentation | 2.44 ± 0.80 | 2.93 ± 0.96 | 0.039 | |||
Mean WFNS grade on presentation | 2.07 ± 1.20 | 3.00 ± 1.60 | 0.012 | |||
Mean Hospitalization days | 24.13 ± 21.50 | 36.46 ± 20.24 | 0.0.045 | |||
Neuroimaging findings | ||||||
Rebleeding of aneurysm | 4 | 2 | 0.280 | 2.577 | 0.427-15.563 | |
Intraventricular hemorrhage on admission | 5 | 6 | 0.003 | 8.8 | 2.223-34.842 | |
Intracerebral hemorrhage on admission | 12 | 3 | 0.72 | 1.229 | 0.3-5.301 | |
Underlying diseases | ||||||
Hypertension | 27 | 6 | 1.0 | 1.086 | 0.348-3.393 | |
Atrial fibrillation | 1 | 0 | 1.0 | 0.824 | 0.746-0.909 | |
Coronary artery diseases | 5 | 1 | 1.0 | 0.943 | 0.102-8.708 | |
Diabetes mellitus | 4 | 3 | 0.098 | 4.188 | 0.83-21.12 | |
End stage renal diseases | 2 | 0 | 1.0 | 0.821 | 0.743-0.908 | |
Other complications following aneurysmal SAH | ||||||
Cerebral infarction | ||||||
Symptomatic vasospasm | 10 | 2 | 1.0 | 0.938 | 0.184-4.799 | |
Seizure | 9 | 5 | 0.063 | 3.444 | 0.957-12.40 | |
Diabetes inspidus | 0 | 2 | 0.029 | 0.155 | 0.094-0.255 | |
Hyponatremia | 5 | 2 | 0.60 | 2.031 | 0.355-11.62 | |
Shunt infection | 1 | 1 | 0.32 | 5.0 | 0.295-84.776 | |
Postoperative intracerebral hemorrhage | 5 | 5 | 0.013 | 6.6 | 1.617-26.945 | |
Arrhythmia | 1 | 1 | 0.320 | 5.0 | 0.295-84.776 | |
Outcome | ||||||
Mean Hospitalization days | 24.13 ± 21.50 | 36.47 ± 20.24 | 0.0452 | |||
Mean GOS at discharge | 3.86 ± 1.16 | 2.93 ± 1.03 | 0.014 | |||
Mean GOS after more than 18 months of follow-up | 4.21 ± 1.19 | 3.33 ± 1.40 | 0.211 | |||